Generic Doxil: FDA Approves Non-Brand-Name Version Of Cancer Drug

* FDA approves Sun Pharma Global FZE's generic Doxil * First generic version to be approved by FDA * Approval expected to relieve shortages By Toni Clarke Feb 4 (Reuters) - U.S. health regulators have approved a generic version of the cancer drug Doxil in a move that could ease a months-long shortage that has threatened the lives of thousands of patients. The U.S. Food and Drug Administration...